Cavalry Biosciences

Developer of therapeutics to treat chronic and rare diseases

placeSan Francisco, California, United States calendar_todayFounded 2021 groups6 employees language cavalry.bio

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 26 times.

YearFilings
20241
20253
20262

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon